Parallel evaluation of antimicrobial peptides derived from the synthetic PAF26 and the human LL37
- 1 April 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 356 (1) , 107-113
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AI052453, AR45676)
- Ministerio de Educación, Cultura y Deporte (BIO2006-09523)
This publication has 24 references indexed in Scilit:
- Antimicrobial properties of derivatives of the cationic tryptophan-rich hexapeptide PAF26Biochemical and Biophysical Research Communications, 2007
- Studies on the Mode of Action of the Antifungal Hexapeptide PAF26Antimicrobial Agents and Chemotherapy, 2006
- Solution Structures of Human LL-37 Fragments and NMR-Based Identification of a Minimal Membrane-Targeting Antimicrobial and Anticancer RegionJournal of the American Chemical Society, 2006
- Expression and potential function of cathelicidin antimicrobial peptides in dermatophytosis and tinea versicolorJournal of Antimicrobial Chemotherapy, 2006
- Stabilisation of mixed peptide/lipid complexes in selective antifungal hexapeptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2004
- Antimicrobial peptides of multicellular organismsNature, 2002
- Innate antimicrobial peptide protects the skin from invasive bacterial infectionNature, 2001
- Bactericidal Activity of Mammalian Cathelicidin-Derived PeptidesInfection and Immunity, 2000
- Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37Journal of Biological Chemistry, 1998
- A simple method for displaying the hydropathic character of a proteinJournal of Molecular Biology, 1982